Abstract
Purpose
Excess sodium intake may contribute to the etiology of hypertension and cardiovascular disease risk. World Health Organization (WHO) recommends a daily sodium intake of less than 2 g. The aim of this study was to estimate the association of sodium intake with obesity in Korean adults. Methods: This study used Dietary intake and Health data on 22,321 subjects aged 30 years and over from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010∼2014. Information on dietary intake was obtained by the one day 24-hour recall method in KNHANES, and sodium intake was classified into five groups (< 2,000 mg, 2,000∼4,000 mg, 4,000∼6,000 mg, 6,000∼8,000 mg, ≥ 8,000 mg). Obesity was defined as having a body mass index (BMI) higher than 25 kg/m2. Intake of sodium and obesity status were analyzed by logistic regression with SPSS Statistics 23. Results: Men tended to have a higher sodium intake than women (p < 0.001). After adjusting for age, sex, year, daily energy intake, education level, smoking status, drinking status, physical activity, and chronic diseases and comparing the highest sodium intake group (≥ 8,000 mg) with the lowest intake group (< 2,000 mg), the OR of obesity was 1.351 (95% CI: 1.032∼1.767) in men. The OR of obesity in the sodium intake group (4,000∼6,000 mg) was 1.232 (95% CI: 1.063∼1.427) in women. Conclusion: Our findings suggest an independent relationship between sodium intake and as increased risk of obesity in Korean adults, implying the necessity for future research on low-sodium diet intervention in relation to obesity.
References
1. Mundstock E, Sarria EE, Zatti H, Mattos Louzada F, Kich Grun L, Herbert Jones M, Guma FT, Mazzola In Memoriam J, Epifanio M, Stein RT, Barb-Tuana FM, Mattiello R. Effect of obesity on telomere length: systematic review and metaanalysis. Obesity (Silver Spring). 2015; 23(11):2165–2174.
3. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010; 362(7):590–599.
4. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012; 70(1):3–21.
5. Khang YH, Park MJ. Trends in obesity among Korean children using four different criteria. Int J Pediatr Obes. 2011; 6(3–4):206–214.
6. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. 2013–2014 National Health Nutrition Examination Survey Report [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2014. [cited 2015 Dec 1]. Available from:. https://knhanes.cdc.go.kr/knhanes/index.do. from:. https://knhanes.cdc.go.kr/knhanes/index.do.
7. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016; 315(21):2284–2291.
9. Lee JH, Reed DR, Price RA. Familial risk ratios for extreme obesity: implications for mapping human obesity genes. Int J Obes Relat Metab Disord. 1997; 21(10):935–940.
10. Slochower J, Kaplan SP, Mann L. The effects of life stress and weight on mood and eating. Appetite. 1981; 2(2):115–125.
11. Lahti-Koski M, Pietinen P, Heliövaara M, Vartiainen E. Associations of body mass index and obesity with physical activity, food choices, alcohol intake, and smoking in the 1982–1997 FINRISK Studies. Am J Clin Nutr. 2002; 75(5):809–817.
12. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim SS, Danaei G, Mozaffarian D. Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (Nutri-CoDE). Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013; 3(12):): e003733.
13. Song DY, Park JE, Shim JE, Lee JE. Trends in the major dish groups and food groups contributing to sodium intake in the Korea National Health and Nutrition Examination Survey 1998–2010. Korean J Nutr. 2013; 46(1):72–85.
14. Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care. 2014; 37(4):950–956.
15. Ma Y, He FJ, MacGregor GA. High salt intake: independent risk factor for obesity? Hypertension. 2015; 66(4):843–849.
16. Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, Loustalot F, Dai S, Gunn JP, Tian N, Cogswell ME, Merritt R. Sodium intake and blood pressure among US children and adolescents. Pediatrics. 2012; 130(4):611–619.
17. Larsen SC, Ängquist L, S⊘rensen TI, Heitmann BL. 24h urinary sodium excretion and subsequent change in weight, waist circumference and body composition. PLoS One. 2013; 8(7):): e69689.
18. Navia B, Aparicio A, Perea JM, Pérez-Farinós N, Villar-Villalba C, Labrado E, Ortega RM. Sodium intake may promote weight gain; results of the FANPE study in a representative sample of the adult Spanish population. Nutr Hosp. 2014; 29(6):1283–1289.
19. Song HJ, Cho YG, Lee HJ. Dietary sodium intake and prevalence of overweight in adults. Metabolism. 2013; 62(5):703–708.
20. Oh HW, Kim HJ, Jun DW, Lee SM. Associations between 24-hour urine sodium excretion level and obesity-related metabolic risk factors. Korean J Community Nutr. 2015; 20(6):460–467.
21. Oh SW, Han KH, Han SY, Koo HS, Kim S, Chin HJ. Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat. Medicine (Baltimore). 2015; 94(39):): e1650.
22. Kim JH, Lim GE, Kang S, Lee K, Park TJ, Kim J. The relationship between daily sodium intake and obesity in Korean adults. Korean J Health Promot. 2015; 15(4):175–184.
23. World Health Organization Western Pacific Region; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Limited;2000.
24. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on sodium and blood pressure: a critical review of current scientific evidence. Hypertension. 2000; 35(4):858–863.
25. Blaustein MP, Hamlyn JM. Role of a natriuretic factor in essential hypertension: an hypothesis. Ann Intern Med. 1983; 98(5 Pt 2):785–792.
26. Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol. 2009; 15(18):2204–2213.
27. Park B, Shin A, Park SK, Ko KP, Ma SH, Lee EH, Gwack J, Jung EJ, Cho LY, Yang JJ, Yoo KY. Ecological study for refrigerator use, salt, vegetable, and fruit intakes, and gastric cancer. Cancer Causes Control. 2011; 22(11):1497–1502.
28. World Health Organization. Guideline. Sodium intake for adults and children. Geneva: World Health Organization;2012.
29. Cocores JA, Gold MS. The salted food addiction hypothesis may explain overeating and the obesity epidemic. Med Hypotheses. 2009; 73(6):892–899.
30. Fonseca-Alaniz MH, Brito LC, Borges-Silva CN, Takada J, Andreotti S, Lima FB. High dietary sodium intake increases white adipose tissue mass and plasma leptin in rats. Obesity (Silver Spring). 2007; 15(9):2200–2208.
31. Fonseca-Alaniz MH, Takada J, Andreotti S, de Campos TB, Cam-paña AB, Borges-Silva CN, Lima FB. High sodium intake enhances insulin-stimulated glucose uptake in rat epididymal adipose tissue. Obesity (Silver Spring). 2008; 16(6):1186–1192.
32. Grimes CA, Riddell LJ, Campbell KJ, Nowson CA. Dietary salt intake, sugar-sweetened beverage consumption, and obesity risk. Pediatrics. 2013; 131(1):14–21.
33. Libuda L, Kersting M, Alexy U. Consumption of dietary salt measured by urinary sodium excretion and its association with body weight status in healthy children and adolescents. Public Health Nutr. 2012; 15(3):433–441.
34. Yoon YS, Oh SW. Sodium density and obesity; the Korea National Health and Nutrition Examination Survey 2007–2010. Eur J Clin Nutr. 2013; 67(2):141–146.
35. Park YS, Son SM, Lim WJ, Kim SB, Chung YS. Comparison of dietary behaviors related to sodium intake by gender and age. Korean J Community Nutr. 2008; 13(1):1–12.
Table 1.
Variables | Total (n = 22,016) | Men (n = 8,792) | Women (n = 13,224) | p-value∗∗ |
---|---|---|---|---|
Age (yr)∗ | 50.76 ± 0.14 | 49.81 ± 0.19 | 51.65 ± 0.19 | < 0.001 |
Height (cm)∗ | 162.97 ± 0.09 | 169.96 ± 0.09 | 156.41 ± 0.08 | < 0.001 |
Weight (kg)∗ | 63.80 ± 0.11 | 70.25 ± 0.15 | 57.74 ± 0.10 | < 0.001 |
BMI (kg/m2)∗ | 23.92 ± 0.03 | 24.26 ± 0.04 | 23.61 ± 0.04 | < 0.001 |
Energy (kcal/day)∗ | 2,025.56 ± 7.95 | 2,464.48 ± 11.96 | 1,707.33 ± 7.92 | < 0.001 |
Sodium (mg/day)∗ | 4,680.38 ± 29.15 | 5,502.59 ± 56.14 | 3,908.35 ± 32.43 | < 0.001 |
Obesity prevalence (%)∗ | 34.3 | 38.6 | 30.2 | < 0.001 |
Chronic disease (%)∗ | ||||
Hypertension | 29.2 | 31.9 | 26.8 | < 0.001 |
Diabetes mellitus | 9.6 | 11.3 | 8.0 | < 0.001 |
Stroke | 1.3 | 1.5 | 1.1 | 0.014 |
Myocardial infarction & angina pectoris | 2.0 | 2.2 | 1.9 | 0.065 |
Hypercholesterolemia | 13.4 | 12.2 | 14.6 | < 0.001 |
Hypertriglyceridemia | 12.7 | 17.3 | 8.4 | < 0.001 |
Education level (%)∗ | < 0.001 | |||
Graduated elementary: ≤ 6 | 22.0 | 14.4 | 29.2 | |
Graduated middle: 7 ∼ 9 | 11.5 | 11.6 | 11.3 | |
Graduated high: 10 ∼ 12 | 33.9 | 34.7 | 33.1 | |
Graduated university: ≥ 13 | 32.7 | 39.3 | 26.4 | |
Pysical activity (%)∗ | < 0.001 | |||
No | 55.3 | 54.2 | 56.3 | |
Yes | 41.6 | 43.1 | 40.3 | |
Smoking status (%)∗ | < 0.001 | |||
Non-smoker | 53.1 | 16.8 | 87.2 | |
Ex-smoker | 20.9 | 37.7 | 5.2 | |
Current smoker | 23.8 | 43.8 | 5.0 | |
Drinking status(%)∗ | < 0.001 | |||
Non-drinker | 11.7 | 4.6 | 18.4 | |
Past drinker | 14.2 | 10.6 | 17.5 | |
Current drinker | 71.8 | 82.8 | 61.4 |
Table 2.
Variables | < 2,000 mg∗∗∗ (n = 3,726) | 2,000 ∼ 4,000 mg (n = 8,246) | 4,000 ∼ 6,000 mg (n = 5,223) | 6,000 ∼ 8,000 mg (n = 2,602) | ≥ 8,000 mg (n = 2,219) | p-value∗∗∗∗ |
---|---|---|---|---|---|---|
Age (year)∗ | 57.20 ± 0.35 | 51.49 ± 0.22 | 49.00 ± 0.24 | 48.11 ± 0.27 | 47.16 ± 0.32 | < 0.001 |
Height (cm)∗ | 157.84 ± 0.18 | 161.62 ± 0.13 | 164.48 ± 0.15 | 165.93 ± 0.21 | 167.13 ± 0.21 | < 0.001 |
Weight (kg)∗ | 59.24 ± 0.23 | 62.24 ± 0.16 | 65.19 ± 0.20 | 66.43 ± 0.30 | 68.45 ± 0.35 | < 0.001 |
BMI (kg/m2)∗ | 23.73 ± 0.07 | 23.75 ± 0.05 | 24.01 ± 0.06 | 24.04 ± 0.08 | 24.40 ± 0.10 | < 0.001 |
Energy (kcal/day)∗ | 1,305.62 ± 10.41 | 1,748.64 ± 8.38 | 2,180.41 ± 11.69 | 2,540.23 ± 19.47 | 2,891.20 ± 22.45 | < 0.001 |
Obesity prevalence (%)∗ | 32.2 | 31.4 | 35.7 | 35.7 | 41.0 | < 0.001 |
Chronic disease (%)∗ | ||||||
Hypertension | 36.2 | 28.6 | 28.7 | 26.0 | 27.1 | < 0.001 |
Hypertension (at exam)∗∗ | 11.3 | 11.7 | 14.2 | 13.9 | 14.7 | 0.003 |
Diabetes mellitus | 12.1 | 9.9 | 8.5 | 8.4 | 8.9 | < 0.001 |
Stroke | 2.2 | 1.6 | 0.9 | 0.8 | 0.6 | < 0.001 |
Myocardial infarction & angina pectoris | 3.2 | 2.1 | 1.7 | 1.7 | 1.4 | < 0.001 |
Hypercholesterolemia | 16.9 | 13.4 | 12.7 | 12.1 | 12.4 | < 0.001 |
Hypertriglyceridemia | 10.9 | 10.9 | 14.3 | 13.5 | 16.1 | < 0.001 |
Education level (%)∗ | < 0.001 | |||||
Graduated elementary: ≤ 6 | 39.7 | 24.0 | 17.4 | 14.1 | 12.5 | |
Graduated middle: 7 ∼ 9 | 12.8 | 11.4 | 11.5 | 11.3 | 10.3 | |
Graduated high: 10 ∼ 12 | 27.2 | 33.7 | 34.8 | 37.0 | 37.1 | |
Graduated university: ≥ 13 | 20.4 | 30.8 | 36.3 | 37.5 | 40.2 | |
Pysical activity (%)∗ | < 0.001 | |||||
No | 55.8 | 54.9 | 56.4 | 54.9 | 53.9 | |
Yes | 39.4 | 41.8 | 40.9 | 43.0 | 44.0 | |
Smoking status (%)∗ | < 0.001 | |||||
Non-smoker | 69.0 | 60.1 | 47.6 | 41.1 | 36.7 | |
Ex-smoker | 13.4 | 18.4 | 22.7 | 25.4 | 29.5 | |
Current smoker | 13.5 | 19.3 | 28.1 | 32.0 | 32.4 | |
Drinking status (%)∗ | < 0.001 | |||||
Non-drinker | 19.9 | 13.1 | 8.9 | 8.3 | 7.2 | |
Past drinker | 18.9 | 15.8 | 12.7 | 11.1 | 9.9 | |
Current drinker | 57.0 | 68.8 | 76.5 | 78.9 | 81.2 |
Table 3.
Variables | < 2,000 mg∗∗∗ | 2,000 ∼ 4,000 mg | 4,000 ∼ 6,000 mg | 6,000 ∼ 8,000 mg | ≥ 8,000 mg | p-value∗∗∗∗ |
---|---|---|---|---|---|---|
(n = 791) | (n = 2,720) | (n = 2,485) | (n = 1,415) | (n = 1,381) | ||
Age (year)∗ | 57.62 ± 0.69 | 51.94 ± 0.32 | 48.53 ± 0.29 | 47.75 ± 0.34 | 46.97 ± 0.37 | < 0.001 |
Height (cm)∗ | 167.14 ± 0.03 | 169.34 ± 0.16 | 170.37 ± 0.16 | 170.68 ± 0.21 | 170.87 ± 0.20 | < 0.001 |
Weight (kg)∗ | 66.65 ± 0.50 | 69.14 ± 0.26 | 70.60 ± 0.25 | 71.09 ± 0.36 | 72.33 ± 0.38 | < 0.001 |
BMI (kg/m2)∗ | 23.78 ± 0.14 | 24.05 ± 0.08 | 24.28 ± 0.07 | 24.36 ± 0.10 | 24.71 ± 0.10 | < 0.001 |
Energy (kcal/day)∗ | 1,220.20 ± 23.66 | 1,460.19 ± 13.98 | 2,750.06 ± 16.51 | 2,210.41 ± 25.26 | 3,850.13 ± 25.93 | < 0.001 |
Obesity prevalence (%)∗ | 33.5 | 34.9 | 39.3 | 39.2 | 45.4 | < 0.001 |
Chronic disease (%)∗ | ||||||
Hypertension | 35.6 | 32.7 | 32.7 | 28.7 | 30.5 | 0.009 |
Hypertension (at exam)∗∗ | 12.8 | 16.4 | 19.1 | 17.5 | 18.2 | 0.078 |
Diabetes mellitus | 16.4 | 13.4 | 9.9 | 9.8 | 9.2 | < 0.001 |
Stroke | 3.8 | 2.1 | 1.2 | 0.8 | 0.6 | < 0.001 |
Myocardial infarction & angina pectoris | 3.8 | 2.4 | 1.9 | 1.9 | 1.7 | 0.002 |
Hypercholesterolemia | 13.7 | 11.5 | 12.6 | 12.1 | 12.3 | < 0.001 |
Hypertriglyceridemia | 15.3 | 14.9 | 19.3 | 17.1 | 19.3 | 0.015 |
Education level (%)∗ | < 0.001 | |||||
Graduated elementary: ≤ 6 | 28.2 | 18.9 | 11.8 | 9.6 | 9.9 | |
Graduated middle: 7 ∼ 9 | 15.0 | 11.6 | 11.9 | 11.6 | 9.8 | |
Graduated high: 10 ∼ 12 | 30.0 | 31.7 | 35.6 | 38.5 | 36.6 | |
Graduated university: ≥ 13 | 26.8 | 37.8 | 40.7 | 40.3 | 43.7 | |
Pysical activity (%)∗ | 0.001 | |||||
No | 53.5 | 53.0 | 56.3 | 54.3 | 53.1 | |
Yes | 41.2 | 43.45 | 41.5 | 44.1 | 45.0 | |
Smoking status (%)∗ | < 0.001 | |||||
Non-smoker | 16.9 | 17.7 | 16.8 | 15.2 | 16.8 | |
Ex-smoker | 38.4 | 39.0 | 36.0 | 36.7 | 38.9 | |
Current smoker | 39.9 | 41.0 | 46.0 | 47.1 | 43.1 | |
Drinking status (%)∗ | < 0.001 | |||||
Non-drinker | 7.7 | 5.4 | 3.6 | 4.4 | 3.9 | |
Past drinker | 16.3 | 12.8 | 9.7 | 9.2 | 7.5 | |
Current drinker | 70.9 | 79.7 | 85.3 | 85.0 | 87.1 |
Table 4.
Variables | < 2,000 mg∗∗∗ | 2,000 ∼ 4,000 mg | 4,000 ∼ 6,000 mg | 6,000 ∼ 8,000 mg | ≥ 8,000 mg | ∗∗∗∗ |
---|---|---|---|---|---|---|
(n = 2,935) | (n = 5,526) | (n = 2,738) | (n = 1,187) | (n = 838) | p-value | |
Age (yr)∗ | 57.07 ± 0.36 | 51.19 ± 0.24 | 49.60 ± 0.31 | 48.76 ± 0.40 | 47.64 ± 0.49 | < 0.001 |
Height (cm)∗ | 154.78 ± 0.15 | 156.54 ± 0.11 | 156.91 ± 0.15 | 157.59 ± 0.22 | 157.64 ± 0.23 | < 0.001 |
Weight (kg)∗ | 56.80 ± 0.20 | 57.71 ± 0.15 | 58.26 ± 0.21 | 58.23 ± 0.33 | 58.61 ± 0.51 | < 0.001 |
BMI (kg/m2)∗ | 23.71 ± 0.08 | 23.56 ± 0.06 | 23.67 ± 0.08 | 23.46 ± 0.13 | 23.59 ± 0.20 | 0.344 |
Energy (kcal/day)∗ | 1,234.29 ± 9.56 | 1,618.92 ± 8.65 | 1,930.36 ± 13.19 | 2,221.88 ± 23.09 | 2,398.68 ± 30.38 | < 0.001 |
Obesity prevalence (%)∗ | 31.8 | 29.2 | 31.1 | 29.7 | 29.9 | 0.268 |
Chronic disease (%)∗ | ||||||
Hypertension | 36.4 | 25.9 | 23.6 | 21.2 | 18.6 | < 0.001 |
Hypertension (at exam)∗∗ | 10.8 | 8.7 | 7.8 | 7.4 | 6.0 | 0.002 |
Diabetes mellitus | 10.7 | 7.7 | 6.8 | 6.1 | 8.3 | < 0.001 |
Stroke | 1.7 | 1.2 | 0.5 | 0.8 | 0.5 | < 0.001 |
Myocardial infarction & angina pectoris | 3.1 | 1.9 | 1.6 | 1.3 | 0.7 | 0.002 |
Hypercholesterolemia | 17.9 | 14.7 | 12.7 | 12.1 | 12.7 | < 0.001 |
Hypertriglyceridemia | 9.5 | 8.3 | 8.0 | 7.2 | 8.0 | 0.029 |
Education level(%)∗ | < 0.001 | |||||
Graduated elementary: ≤ 6 | 43.4 | 27.4 | 24.6 | 2.3 | 19.1 | |
Graduated middle: 7 ∼ 9 | 12.0 | 11.3 | 11.0 | 10.8 | 11.5 | |
Graduated high: 10 ∼ 12 | 26.3 | 35.1 | 33.8 | 34.4 | 38.3 | |
Graduated university: ≥ 13 | 18.3 | 26.3 | 30.6 | 32.5 | 31.1 | |
Pysical activity (%)∗ | 0.173 | |||||
No | 56.5 | 56.1 | 56.6 | 56.1 | 56.1 | |
Yes | 38.8 | 40.7 | 40.3 | 40.9 | 41.4 | |
Smoking status (%)∗ | 0.091 | |||||
Non-smoker | 86.2 | 87.9 | 87.1 | 86.5 | 87.2 | |
Ex-smoker | 5.2 | 4.9 | 5.6 | 5.5 | 5.7 | |
Current smoker | 4.8 | 5.0 | 5.1 | 5.6 | 5.3 | |
Drinking status (%)∗ | < 0.001 | |||||
Non-drinker | 23.9 | 18.1 | 15.8 | 15.1 | 15.5 | |
Past drinker | 19.7 | 17.8 | 16.6 | 14.5 | 16.2 | |
Current drinker | 52.5 | 61.8 | 65.1 | 68.2 | 66.2 |
Table 5.
Sodium intake (mg/day) | Unadjusted OR (95% CI) | Adjusted OR (95% CI)∗∗ | |
---|---|---|---|
Obesity∗ | |||
Total | < 2,000 mg | 1 | 1 |
2,000 ∼ 4,000 mg | 0.965 (0.875 ∼ 1.064) | 0.993 (0.891 ∼ 1.107) | |
4,000 ∼ 6,000 mg | 1.169 (1.052 ∼ 1.300) | 1.126 (1.994 ∼ 1.276) | |
6,000 ∼ 8,000 mg | 1.170 (1.032 ∼ 1.327) | 1.112 (0.959 ∼ 1.291) | |
≥ 8,000 mg | 1.462 (1.283 ∼ 1.667) | 1.358 (1.156 ∼ 1.595) | |
Men | < 2,000 mg | 1 | 1 |
2,000 ∼ 4,000 mg | 1.063 (0.856 ∼ 1.319) | 0.961 (0.765 ∼ 1.208) | |
4,000 ∼ 6,000 mg | 1.286 (1.037 ∼ 1.595) | 1.066 (0.839 ∼ 1.354) | |
6,000 ∼ 8,000 mg | 1.279 (1.018 ∼ 1.607) | 1.066 (0.824 ∼ 1.380) | |
≥8,000 mg | 1.648 (1.312 ∼ 2.070) | 1.351 (1.032 ∼ 1.767) | |
Women | < 2,000 mg | 1 | 1 |
2,000 ∼ 4,000 mg | 0.884 (0.794 ∼ 0.985) | 1.066 (0.944 ∼ 1.203) | |
4,000 ∼ 6,000 mg | 0.967 (0.852 ∼ 1.099) | 1.232 (1.063 ∼ 1.427) | |
6,000 ∼ 8,000 mg | 0.905 (0.763 ∼ 1.073) | 1.198 (0.984 ∼ 1.459) | |
≥ 8,000 mg | 0.914 (0.747 ∼ 1.120) | 1.229 (0.977 ∼ 1.548) |